{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T22:31:18Z","timestamp":1792276278654,"version":"4.4.0"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["NeuroToxicology"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1016\/j.neuro.2015.09.002","type":"journal-article","created":{"date-parts":[[2015,9,4]],"date-time":"2015-09-04T10:40:50Z","timestamp":1441363250000},"page":"1-9","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Structure-dependent inhibition of the human \u03b1 1 \u03b2 2 \u03b3 2 GABA A receptor by piperazine derivatives: A novel mode of action"],"prefix":"10.1016","volume":"51","author":[{"given":"Laura","family":"Hondebrink","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elise J.P.","family":"Hermans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6227-9620","authenticated-orcid":false,"given":"Stijn","family":"Schmeink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Regina G.D.M.","family":"van Kleef","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Meulenbelt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Remco H.S.","family":"Westerink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.neuro.2015.09.002_bib0005","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.drugalcdep.2011.10.007","article-title":"Piperazine compounds as drugs of abuse","volume":"122","author":"Arbo","year":"2012","journal-title":"Drug Alcohol Depend."},{"issue":"44","key":"10.1016\/j.neuro.2015.09.002_bib0010","doi-asserted-by":"publisher","first-page":"45291","DOI":"10.1074\/jbc.X400008200","article-title":"A tribute to the Xenopus laevis oocyte and egg","volume":"279","author":"Brown","year":"2004","journal-title":"J. Biol. Chem."},{"issue":"17\u201318","key":"10.1016\/j.neuro.2015.09.002_bib0015","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1016\/j.drudis.2009.06.009","article-title":"The complexity of the GABAA receptor shapes unique pharmacological profiles","volume":"14","author":"D\u2019Hulst","year":"2009","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.neuro.2015.09.002_bib0020","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1017\/S1461145799001303","article-title":"Pharmacokinetics of trazodone and its major metabolite m-chlorophenylpiperazine in plasma and brain of rats","volume":"2","author":"DeVane","year":"1999","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.neuro.2015.09.002_bib0025","series-title":"Annual Report 2012: The State of the Drugs Problem in Europe","author":"EMCDDA, European Monitoring Centre for Drugs and Drug Addiction","year":"2012"},{"issue":"1","key":"10.1016\/j.neuro.2015.09.002_bib0030","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1093\/toxsci\/kfq257","article-title":"Activation and potentiation of human GABAA receptors by non-dioxin-like PCBs depends on chlorination pattern","volume":"118","author":"Fernandes","year":"2010","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.neuro.2015.09.002_bib0035","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejphar.2004.03.014","article-title":"Flumazenil-independent positive modulation of \u03b3-aminobutyric acid action by 6-methylflavone at human \u03b11\u03b22\u03b32L and \u03b11\u03b22GABAA receptors","volume":"491","author":"Hall","year":"2004","journal-title":"Eur. J. Pharmacol."},{"issue":"2","key":"10.1016\/j.neuro.2015.09.002_bib0040","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1093\/toxsci\/kfq284","article-title":"PCB-47, PBDE-47, and 6-OH-PBDE-47 differentially modulate human GABAA and alpha4beta2 nicotinic acetylcholine receptors","volume":"118","author":"Hendriks","year":"2010","journal-title":"Toxicol. Sci."},{"issue":"6","key":"10.1016\/j.neuro.2015.09.002_bib0045","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1016\/j.neuro.2011.05.016","article-title":"Modulation of human GABAA receptor function: a novel mode of action of drugs of abuse","volume":"32","author":"Hondebrink","year":"2011","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.neuro.2015.09.002_bib0050","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.neuro.2012.12.003","article-title":"Additive inhibition of human \u03b11\u03b22\u03b32 GABAA receptors by mixtures of commonly used drugs of abuse","volume":"35","author":"Hondebrink","year":"2013","journal-title":"Neurotoxicology"},{"issue":"3","key":"10.1016\/j.neuro.2015.09.002_bib0055","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1007\/BF02244603","article-title":"Effects of m-chlorophenylpiperazine in normal subjects: a dose-response study","volume":"100","author":"Kahn","year":"1990","journal-title":"Psychopharmacology (Berl)"},{"issue":"4","key":"10.1016\/j.neuro.2015.09.002_bib0060","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1016\/S0306-4522(98)00054-2","article-title":"Heterogeneity of ventral tegmental area neurons: single-unit recording and iontophoresis in awake, unrestrained rats","volume":"85","author":"Kiyatkin","year":"1998","journal-title":"Neuroscience"},{"issue":"3","key":"10.1016\/j.neuro.2015.09.002_bib0065","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/S0165-1781(98)00044-4","article-title":"Serotonin syndrome after challenge with the 5-HT agonist meta-chlorophenylpiperazine","volume":"79","author":"Klaassen","year":"1998","journal-title":"Psychiatry Res."},{"issue":"3","key":"10.1016\/j.neuro.2015.09.002_bib0070","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1097\/FTD.0b013e318170a879","article-title":"Acute chlorophenylpiperazine overdose: a case report and review of the literature","volume":"30","author":"Kovaleva","year":"2008","journal-title":"Ther. Drug Monit."},{"issue":"4","key":"10.1016\/j.neuro.2015.09.002_bib0075","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1093\/jat\/29.4.262","article-title":"Investigation of a fatality due to trazodone poisoning: case report and literature review","volume":"29","author":"Martinez","year":"2005","journal-title":"J. Anal. Toxicol."},{"issue":"4","key":"10.1016\/j.neuro.2015.09.002_bib0080","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/S0166-2236(96)80023-3","article-title":"Which GABAA-receptor subtypes really occur in the brain?","volume":"19","author":"McKernan","year":"1996","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.neuro.2015.09.002_bib0085","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/S0378-4347(00)83297-1","article-title":"Analysis of trazodone and m-chlorophenylpiperazine in plasma and brain tissue by high-performance liquid chromatography","volume":"374","author":"Miller","year":"1986","journal-title":"J. Chromatogr."},{"issue":"2\u20133","key":"10.1016\/j.neuro.2015.09.002_bib0090","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.ejphar.2006.11.075","article-title":"The effects of non-medically used psychoactive drugs on monoamine neurotransmission in rat brain","volume":"559","author":"Nagai","year":"2007","journal-title":"Eur. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.neuro.2015.09.002_bib0095","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.resuscitation.2006.11.010","article-title":"Should a benzodiazepine antagonist be used in unconscious patients presenting to the emergency department?","volume":"74","author":"Ngo","year":"2007","journal-title":"Resuscitation"},{"issue":"11","key":"10.1016\/j.neuro.2015.09.002_bib0100","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1016\/S0006-3223(97)00483-6","article-title":"Human CYP2D6 and metabolism of m-chlorophenyl-piperazine","volume":"44","author":"Rotzinger","year":"1998","journal-title":"Biol. Psychiatry"},{"issue":"9","key":"10.1016\/j.neuro.2015.09.002_bib0105","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1038\/nrd3502","article-title":"Beyond classical benzodiazepines: novel therapeutic potential of GABAA receptor subtypes","volume":"10","author":"Rudolph","year":"2011","journal-title":"Nat. Rev. Drug Discov."},{"issue":"3","key":"10.1016\/j.neuro.2015.09.002_bib0110","doi-asserted-by":"publisher","first-page":"131","DOI":"10.3109\/15563650.2011.572076","article-title":"The clinical toxicology of the designer \u201cparty pills\u201d benzylpiperazine and trifluoromethylphenylpiperazine","volume":"49","author":"Schep","year":"2011","journal-title":"Clin. Toxicol. (Phila.)"},{"issue":"3","key":"10.1016\/j.neuro.2015.09.002_bib0115","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/0165-1781(94)90051-5","article-title":"Effects of alprazolam on increases in hormonal and anxiety levels induced by meta-chlorophenylpiperazine","volume":"53","author":"Sevy","year":"1994","journal-title":"Psychiatry Res."},{"issue":"11","key":"10.1016\/j.neuro.2015.09.002_bib0120","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1016\/0028-3908(85)90193-5","article-title":"Trazodone and m-chlorophenylpiperazine. Concentration in brain and receptor activity in regions in the brain associated with anxiety","volume":"24","author":"Smith","year":"1985","journal-title":"Neuropharmacology"},{"issue":"6","key":"10.1016\/j.neuro.2015.09.002_bib0125","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1016\/0006-3223(95)00470-X","article-title":"m-Chlorophenylpiperazine challenge in borderline personality disorder: relationship of neuroendocrine response, behavioral response, and clinical measures","volume":"40","author":"Stein","year":"1996","journal-title":"Biol. Psychiatry"},{"issue":"12","key":"10.1016\/j.neuro.2015.09.002_bib0130","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1038\/81800","article-title":"Benzodiazepines act on GABAA receptors via two distinct and separable mechanisms","volume":"3","author":"Walters","year":"2000","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuro.2015.09.002_bib0135","series-title":"1-(3-chlorophenyl)piperazine (mCPP) Pre-Review Report. Thirty-fifth Meeting","article-title":"World Health Organization and Expert Committee on Drug Dependence","author":"WHO","year":"2012"},{"issue":"9571","key":"10.1016\/j.neuro.2015.09.002_bib0140","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1016\/S0140-6736(07)60674-6","article-title":"Collapse, reported seizure-and an unexpected pill","volume":"369","author":"Wood","year":"2007","journal-title":"Lancet"}],"container-title":["NeuroToxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161813X1500131X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161813X1500131X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,19]],"date-time":"2018-09-19T14:27:28Z","timestamp":1537367248000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161813X1500131X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":28,"alternative-id":["S0161813X1500131X"],"URL":"https:\/\/doi.org\/10.1016\/j.neuro.2015.09.002","relation":{},"ISSN":["0161-813X"],"issn-type":[{"value":"0161-813X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Structure-dependent inhibition of the human \u03b11\u03b22\u03b32 GABAA receptor by piperazine derivatives: A novel mode of action","name":"articletitle","label":"Article Title"},{"value":"NeuroToxicology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuro.2015.09.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}